Cargando…

CS15-03 Prevention of HCC Related to Viral Hepatitis

Detalles Bibliográficos
Autor principal:	Cheng, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society for Infectious Diseases. Published by Elsevier Ltd. 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129036/ http://dx.doi.org/10.1016/S1201-9712(09)60304-0

Ejemplares similares

CS15-02 Current Japanese Strategies for Preventing HCC Development
por: Ueno, Yoshiyuki
Publicado: (2009)

CS15-01 Can We Prevent Hepatocellular Carcinoma in Chronic Hepatitis B?
por: Chan, Henry L.Y.
Publicado: (2009)

OR15-03 Lower Hepatic Mitochondrial Respiration Relates To Dysmetabolism In Adolescents With Severe Obesity
por: Finn, Erin, et al.
Publicado: (2023)

Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development
por: Virzì, Alessia, et al.
Publicado: (2021)

E-RUA 03 Vol. 15
por: Martí Capitanachi, Daniel Rolando
Publicado: (2023)

The role of lamivudine versus entecavir in prevention of HCC in patients with hepatitis B virus-related cirrhosis
por: Olariu, Cristina, et al.
Publicado: (2013)

Tertiary Prevention of HCC in Chronic Hepatitis B or C Infected Patients
por: Teng, Wei, et al.
Publicado: (2021)

CS-03 LARGE CYSTIC INTRADURAL SCHWANNOMA IN CERVICAL REGION: A CASE REPORT
por: Takeshima, Yuki, et al.
Publicado: (2019)

EX-SE Meeting - 15/03/89
por: Claude
Publicado: (1989)

CS15.1 CMV in transplant recipients
por: Tan, B.-H.
Publicado: (2011)

PA03.15. Study on relation of Prakriti with academic stress in school going children
por: Madhukar, Atika, et al.
Publicado: (2013)

Viral integration drives multifocal HCC during the occult HBV infection
por: Chen, Xiao-Ping, et al.
Publicado: (2019)

Editorial: Viral Hepatitis: Pathophysiology, Prevention, and Control
por: Kao, Cheng, et al.
Publicado: (2021)

Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
por: Zhang, Xinhe, et al.
Publicado: (2021)

Correction to: Viral integration drives multifocal HCC during the occult HBV infection
por: Chen, Xiao-Ping, et al.
Publicado: (2019)

Comparison between using hepatocellular carcinoma (HCC) risk scores and the HCC national guideline to identify high‐risk chronic hepatitis B patients for HCC surveillance in Thailand
por: Rattananukrom, Chitchai, et al.
Publicado: (2022)

P03-020 - A novel 15-HPGD mutation in pachydermoperiostosis
por: Erken, E, et al.
Publicado: (2013)

Dihydroartemisinin Induces Ferroptosis in HCC by Promoting the Formation of PEBP1/15-LO
por: Su, Ying, et al.
Publicado: (2021)

Restoration of CD4(+) T Cells during NAFLD without Modulation of the Hepatic Immunological Pattern Is Not Sufficient to Prevent HCC
por: Isbell, Madison, et al.
Publicado: (2022)

COVID-19 – Journal de bord – 15/03/2020 : premières réflexions…
por: Lorette, Gérard
Publicado: (2020)

Hepatic FTO is dispensable for the regulation of metabolism but counteracts HCC development in vivo
por: Mittenbühler, Melanie J., et al.
Publicado: (2020)

Cortaillod 21.1.03 Techmeta 26.03.03 CMS SUPRA
Publicado: (2003)

HCC, diet and metabolic factors: Diet and HCC
por: Montella, Maurizio, et al.
Publicado: (2011)

COVID 19 – Journal de bord – 15/03/2020 : premières réflexions
Publicado: (2020)

Booster Operation Committee: Minutes of the 48th meeting (15.03.1978)
por: Dekkers, D, et al.
Publicado: (1978)

Elevated FBXL18 promotes RPS15A ubiquitination and SMAD3 activation to drive HCC
por: Yu, Hong-Qiang, et al.
Publicado: (2023)

EXM-86-03: 13/03/1986
por: Malandain, E
Publicado: (1986)

Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2019)

The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathways
por: Shoraka, Shahrzad, et al.
Publicado: (2023)

MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014)

Downregulation of 15-PGDH enhances MASH-HCC development via fatty acid-induced T-cell exhaustion
por: Hu, Xichen, et al.
Publicado: (2023)

Compte rendu de la réunion de briefing du 15.03.1993
por: Boillot, J, et al.
Publicado: (1993)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
por: Huang, Yan, et al.
Publicado: (2022)

The paradox of immunotherapy in NASH-HCC
por: Peng, Yao, et al.
Publicado: (2021)

Low prevalence of hepatitis C infection in hepatocellular carcinoma (HCC) cases and population controls in Guangxi, a hyperendemic region for HCC in the People's Republic of China.
por: Yuan, J. M., et al.
Publicado: (1996)

Corrigendum: Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2020)

Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC
por: Liu, Lei, et al.
Publicado: (2022)

Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC
por: Yeh, Shiou-Hwei, et al.
Publicado: (2023)

Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC
por: Baraka, Kholoud, et al.
Publicado: (2023)

CS-03 BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young
por: Hayashi, Takahiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aokrdvm1nna1pa2puoi5j5hnsb